Viewing Study NCT05247905


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-26 @ 2:07 AM
Study NCT ID: NCT05247905
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-02
First Post: 2022-02-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module